Brief: VTV Therapeutics Announces CEO Transition
04/03/2022 01:53
March 3 (Reuters) - vTv Therapeutics Inc VTVT.O :
* VTV THERAPEUTICS ANNOUNCES CEO TRANSITION
* SAYS APPOINTED RICH NELSON AS ACTING CHIEF EXECUTIVE
OFFICER
* CO'S CURRENT CEO AND MEMBER OF BOARD OF DIRECTORS, DEEPA
PRASAD,
HAS INFORMED CO THAT SHE WILL BE RESIGNING
Source text for Eikon: ID:nPn89ylTza
Further company coverage: VTVT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on vTv Therapeutics
See all newsBrief: Vtv Therapeutics Announces FDA Orphan Drug Designation For Hppd In Sickle Cell Disease
vTv Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
vTv Therapeutics Inc expected to post a loss of $1.04 a share - Earnings Preview
vTv Therapeutics Q2 net loss widens on higher trial costs
Brief: VTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)